Is Insulin human + Insulin isophane registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 2 valid registrations of Insulin human + Insulin isophane, including MIXTARD 30 (70,30 IU/ml,IU/ml, Suspension, SAR 65.00); MIXTARD 30 PENFILL (70,30 IU/ml,IU/ml, Suspension for injection, SAR 103.35).

Active substances

Insulin human + Insulin isophane

SFDA 3

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
MIXTARD 30	70,30 IU/ml,IU/ml	Suspension · Subcutaneous use	1 Vial	SAR 65.00	Biological · Prescription	NOVO NORDISK	Valid
MIXTARD 30 PENFILL	70,30 IU/ml,IU/ml	Suspension for injection · Subcutaneous use	5 Cartridge	SAR 103.35	Biological · Prescription	NOVO NORDISK	Valid
MIXTARD 50 PENFILL	50,50 IU/ml,IU/ml	Suspension for injection · Subcutaneous use	5 Cartridge	SAR 103.35	Biological · Prescription	NOVO NORDISK	Withdrawn by MAH · Not Marketed

Indications — CHI Daman Drug Formulary

DIABETES MELLITUS TYPE 1; DIABETES MELLITUS TYPE 2

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.